ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 141 filers reported holding ESPERION THERAPEUTICS INC NE in Q3 2021. The put-call ratio across all filers is 1.72 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $304,562 | -31.9% | 310,778 | -3.4% | 0.00% | 0.0% |
| Q2 2023 | $447,310 | -18.9% | 321,806 | -7.2% | 0.00% | -50.0% |
| Q1 2023 | $551,587 | -66.1% | 346,910 | +32.7% | 0.00% | -50.0% |
| Q4 2022 | $1,628,217 | +757.0% | 261,351 | +1559.0% | 0.00% | – |
| Q3 2021 | $190,000 | -54.4% | 15,754 | -20.0% | 0.00% | -100.0% |
| Q2 2021 | $417,000 | +27.5% | 19,699 | +69.2% | 0.00% | – |
| Q1 2021 | $327,000 | -41.8% | 11,642 | -3.6% | 0.00% | -100.0% |
| Q2 2019 | $562,000 | +26.0% | 12,078 | +8.8% | 0.01% | 0.0% |
| Q1 2019 | $446,000 | +195.4% | 11,100 | +237.4% | 0.01% | +400.0% |
| Q4 2018 | $151,000 | -62.9% | 3,290 | -64.2% | 0.00% | -66.7% |
| Q3 2018 | $407,000 | -72.6% | 9,183 | -75.8% | 0.00% | -76.9% |
| Q2 2018 | $1,485,000 | +3.6% | 37,891 | +91.1% | 0.01% | -7.1% |
| Q1 2018 | $1,434,000 | +349.5% | 19,828 | +309.6% | 0.01% | +600.0% |
| Q4 2017 | $319,000 | -36.2% | 4,841 | -55.2% | 0.00% | -60.0% |
| Q2 2017 | $500,000 | -75.7% | 10,810 | -81.5% | 0.01% | -79.2% |
| Q1 2017 | $2,059,000 | +3389.8% | 58,312 | +1142.8% | 0.02% | +2300.0% |
| Q4 2016 | $59,000 | +391.7% | 4,692 | +297.0% | 0.00% | – |
| Q2 2016 | $12,000 | -93.3% | 1,182 | -88.8% | 0.00% | -100.0% |
| Q1 2016 | $179,000 | -46.7% | 10,575 | -25.8% | 0.00% | -40.0% |
| Q3 2015 | $336,000 | -83.1% | 14,248 | -33.7% | 0.01% | -83.9% |
| Q1 2015 | $1,989,000 | +593.0% | 21,484 | +202.6% | 0.03% | +675.0% |
| Q4 2014 | $287,000 | – | 7,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 4,468,835 | $20,735,000 | 8.65% |
| Altium Capital Management LP | 2,496,524 | $11,584,000 | 3.88% |
| Deep Track Capital, LP | 6,000,000 | $27,840,000 | 1.78% |
| Paradigm Biocapital Advisors LP | 1,157,246 | $5,370,000 | 1.42% |
| Monaco Asset Management SAM | 419,262 | $1,945,000 | 0.77% |
| Rhenman & Partners Asset Management AB | 981,582 | $4,555,000 | 0.45% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 2,713,176 | $12,589,000 | 0.39% |
| Bellevue Group AG | 4,299,164 | $19,948,000 | 0.23% |
| WASATCH ADVISORS LP | 8,147,380 | $37,804,000 | 0.19% |
| Telemetry Investments, L.L.C. | 17,500 | $81,000 | 0.13% |